Fate Therapeutics Inc (FATE)
3.795
-0.08
(-1.94%)
USD |
NASDAQ |
Apr 26, 16:00
3.795
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Total Assets (Quarterly): 506.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 506.22M |
| September 30, 2023 | 543.79M |
| June 30, 2023 | 584.76M |
| March 31, 2023 | 630.34M |
| December 31, 2022 | 705.56M |
| September 30, 2022 | 749.35M |
| June 30, 2022 | 807.06M |
| March 31, 2022 | 858.39M |
| December 31, 2021 | 921.46M |
| September 30, 2021 | 984.57M |
| June 30, 2021 | 1.016B |
| March 31, 2021 | 1.046B |
| December 31, 2020 | 622.46M |
| September 30, 2020 | 626.44M |
| June 30, 2020 | 653.59M |
| March 31, 2020 | 321.89M |
| December 31, 2019 | 302.27M |
| September 30, 2019 | 340.21M |
| June 30, 2019 | 199.88M |
| March 31, 2019 | 220.86M |
| December 31, 2018 | 213.03M |
| September 30, 2018 | 219.95M |
| Date | Value |
|---|---|
| June 30, 2018 | 83.16M |
| March 31, 2018 | 93.42M |
| December 31, 2017 | 105.29M |
| September 30, 2017 | 72.68M |
| June 30, 2017 | 73.95M |
| March 31, 2017 | 85.33M |
| December 31, 2016 | 95.05M |
| September 30, 2016 | 49.30M |
| June 30, 2016 | 49.18M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 67.96M |
| September 30, 2015 | 76.40M |
| June 30, 2015 | 83.48M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 51.18M |
| September 30, 2014 | 47.01M |
| June 30, 2014 | 43.55M |
| March 31, 2014 | 49.65M |
| December 31, 2013 | 55.58M |
| September 30, 2013 | 23.04M |
| June 30, 2013 | 6.173M |
| December 31, 2012 | 11.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
199.88M
Minimum
Jun 2019
1.046B
Maximum
Mar 2021
653.68M
Average
630.34M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 777.88M |
| Regeneron Pharmaceuticals Inc | 33.08B |
| Sarepta Therapeutics Inc | 3.265B |
| ADMA Biologics Inc | 329.18M |
| Ocular Therapeutix Inc | 252.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 137.80M |
| Shareholders Equity (Quarterly) | 368.42M |
| Current Ratio | 8.481 |